Developmental differences between newborn and adult mice in response to romiplostim
暂无分享,去创建一个
H. Feldman | Viola Lorenz | M. Sola-Visner | Zhi-jian Liu | H. Ramsey | Katherine A. Sparger | Nan Li | Tahirih Laforest | Haley E. Ramsey
[1] A. Raj,et al. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study , 2016, The Lancet.
[2] J. Bussel,et al. Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies. , 2015, Blood.
[3] F. Candotti,et al. Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott–Aldrich Syndrome , 2015, Front. Pediatr..
[4] D. Mager,et al. Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan. , 2014, Blood.
[5] C. Dame,et al. Low immature platelet fraction suggests decreased megakaryopoiesis in neonates with sepsis or necrotizing enterocolitis , 2013, Journal of Perinatology.
[6] P. Agrawal,et al. A de novo T73I Mutation in PTPN11 in a Neonate with Severe and Prolonged Congenital Thrombocytopenia and Noonan Syndrome , 2013, Neonatology.
[7] A. Balduini,et al. High Doses of Romiplostim Induce Proliferation and Reduce Proplatelet Formation by Human Megakaryocytes , 2013, PloS one.
[8] L. Rimsza,et al. Developmental differences in megakaryocyte size in infants and children. , 2012, American journal of clinical pathology.
[9] L. Rimsza,et al. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. , 2011, Blood.
[10] C. Dame,et al. Immature platelet values indicate impaired megakaryopoietic activity in neonatal early-onset thrombocytopenia , 2010, Thrombosis and Haemostasis.
[11] L. Rimsza,et al. Differences between Newborn and Adult Mice in Their Response to Immune Thrombocytopenia , 2010, Neonatology.
[12] J. Burnett,et al. Very high users of platelet transfusions in the neonatal intensive care unit , 2009, Transfusion.
[13] G. Schmalisch,et al. Immature platelet fraction as novel laboratory parameter predicting the course of neonatal thrombocytopenia , 2009, British journal of haematology.
[14] L. Rimsza,et al. Effects of Sepsis on Neonatal Thrombopoiesis , 2008, Pediatric Research.
[15] Alan D Hutson,et al. Megakaryocyte Size and Concentration in the Bone Marrow of Thrombocytopenic and Nonthrombocytopenic Neonates , 2007, Pediatric Research.
[16] L. Rimsza,et al. Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. , 2006, Blood.
[17] T. Kiehn,et al. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system , 2006, Journal of Perinatology.
[18] Y. Abe,et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). , 2006, Thrombosis research.
[19] D. Hart,et al. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia , 2004, British journal of haematology.
[20] C. Dame. Developmental biology of thrombopoietin in the human fetus and neonate , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[21] D. Theriaque,et al. Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions , 2001, Transfusion.
[22] R. Christensen,et al. Dose–response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non‐thrombocytopenic neonates to recombinant thrombopoietin , 2000, British journal of haematology.
[23] W. Jelkmann,et al. Expression of the thrombopoietin gene in human fetal and neonatal tissues. , 1999, Blood.
[24] D. Calhoun,et al. Plasma thrombopoietin concentrations in thrombocytopenic and non‐thrombocytopenic patients in a neonatal intensive care unit , 1999, British journal of haematology.
[25] J. Dame,et al. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development. , 1999, Early human development.
[26] A. Roberts,et al. Endogenous Thrombopoietin Levels and Effect of Recombinant Human Thrombopoietin on Megakaryocyte Precursors in Term and Preterm Babies , 1998, Pediatric Research.
[27] I. Roberts,et al. Circulating Megakaryocytes and Their Progenitors in Early Thrombocytopenia in Preterm Neonates , 1996, Pediatric Research.
[28] R. Warwick,et al. In vitro culture of colony forming unit‐megakaryocyte (CFU‐MK) in fetal alloimmune thrombocytopenia , 1994, British journal of haematology.
[29] J. Kelton,et al. Clinical impact of neonatal thrombocytopenia. , 1987, The Journal of pediatrics.
[30] J. Kelton,et al. Frequency and mechanism of neonatal thrombocytopenia. , 1986, The Journal of pediatrics.
[31] F. Mimouni,et al. THROMBOCYTOPENIA IN SMALL‐FOR‐GESTATIONAL‐AGE INFANTS , 1983, Acta paediatrica Scandinavica.
[32] L Neumann,et al. Thrombocytopenia in the high-risk infant. , 1980, The Journal of pediatrics.